全文获取类型
收费全文 | 57434篇 |
免费 | 5526篇 |
国内免费 | 2242篇 |
专业分类
耳鼻咽喉 | 629篇 |
儿科学 | 1439篇 |
妇产科学 | 939篇 |
基础医学 | 7161篇 |
口腔科学 | 968篇 |
临床医学 | 7432篇 |
内科学 | 8988篇 |
皮肤病学 | 870篇 |
神经病学 | 4351篇 |
特种医学 | 1873篇 |
外国民族医学 | 17篇 |
外科学 | 6672篇 |
综合类 | 5653篇 |
现状与发展 | 7篇 |
一般理论 | 29篇 |
预防医学 | 5537篇 |
眼科学 | 1304篇 |
药学 | 5317篇 |
18篇 | |
中国医学 | 1839篇 |
肿瘤学 | 4159篇 |
出版年
2023年 | 637篇 |
2022年 | 1169篇 |
2021年 | 2340篇 |
2020年 | 1630篇 |
2019年 | 1812篇 |
2018年 | 1974篇 |
2017年 | 1714篇 |
2016年 | 1599篇 |
2015年 | 2055篇 |
2014年 | 2718篇 |
2013年 | 2967篇 |
2012年 | 4251篇 |
2011年 | 4448篇 |
2010年 | 2623篇 |
2009年 | 2177篇 |
2008年 | 3158篇 |
2007年 | 3104篇 |
2006年 | 2934篇 |
2005年 | 2899篇 |
2004年 | 2315篇 |
2003年 | 2203篇 |
2002年 | 2005篇 |
2001年 | 1316篇 |
2000年 | 1168篇 |
1999年 | 1086篇 |
1998年 | 639篇 |
1997年 | 555篇 |
1996年 | 500篇 |
1995年 | 456篇 |
1994年 | 418篇 |
1993年 | 324篇 |
1992年 | 555篇 |
1991年 | 537篇 |
1990年 | 500篇 |
1989年 | 462篇 |
1988年 | 395篇 |
1987年 | 381篇 |
1986年 | 297篇 |
1985年 | 307篇 |
1984年 | 233篇 |
1983年 | 199篇 |
1982年 | 142篇 |
1981年 | 123篇 |
1980年 | 130篇 |
1979年 | 184篇 |
1978年 | 149篇 |
1977年 | 115篇 |
1976年 | 106篇 |
1974年 | 135篇 |
1973年 | 119篇 |
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
1.
2.
人工智能(Artificial Intelligence,AI)的蓬勃兴起为现代社会带来了前所未有的机遇,中医药是中华民族传承千年的文化瑰宝。随着人工智能技术不断在中医药领域的科技创新中崭露头角,二者的融合不断加深,人工智能在中医药领域的发展前景、争议挑战也引发了诸多思考。本文将从人工智能在中医药领域的应用入手,对人工智能辅助中医诊断、智能决策与数据挖掘、健康管理及中草药现代化研究等方面,就近年来国内外研究进展进行总结与分析,以期为AI视域下实现中医药现代化、智能化赋能。 相似文献
3.
目的以基因表达数据集资料为研究对象,分析BCAN基因在肾透明细胞癌中的表达情况以及对患者预后的影响。方法在Oncomine数据库中挖掘BCAN在肾透明细胞癌(ccRCC)中的表达情况。从TCGA数据库中获取ccRCC患者临床资料和目的基因的表达信息并进行统计分析。利用GEO数据库中GSE73731数据集的ccRCC样本进行基因富集分析。利用String数据库分析与BCAN相关的蛋白。结果BCAN低表达组的ccRCC患者在病理分期及T分期方面低于高表达组(P<0.001;P=0.001);N分期及M分期差异无统计学意义(P>0.05)。BCAN低表达组患者的总生存期优于高表达组(P=0.033)。BCAN基因高表达组的样本主要富集在KRAS信号通路。结论BCAN可以通过多种途径来促进肿瘤细胞的侵袭能力,有望成为ccRCC不良预后的重要生物标志物之一。 相似文献
4.
5.
6.
7.
William R. C. Knight Cara R. Baker Nyree Griffin Wahyu Wulaningsih Mark Kelly Andrew R. Davies James A. Gossage 《British journal of cancer》2021,124(10):1653
Background A high Mandard score implies a non-response to chemotherapy in oesophageal adenocarcinoma. However, some patients exhibit tumour volume reduction and a nodal response despite a high score. This study examines survival and recurrence patterns in these patients.Methods Clinicopathological factors were analysed using multivariable Cox regression assessing time to death and recurrence. Computed tomography-estimated tumour volume change was examined in a subgroup of consecutive patients.Results Five hundred and fifty-five patients were included. Median survival was 55 months (Mandard 1–3) and 21 months (Mandard 4 and 5). In the Mandard 4 and 5 group (332 patients), comparison between complete nodal responders and persistent nodal disease showed improved survival (90 vs 18 months), recurrence rates (locoregional 14.75 vs 28.74%, systemic 24.59 vs 48.42%) and circumferential resection margin positivity (22.95 vs 68.11%). Complete nodal response independently predicted improved survival (hazard ratio 0.34 (0.16–0.74). Post-chemotherapy tumour volume reduction was greater in patients with a complete nodal response (−16.3 vs −7.7 cm3, p = 0.033) with no significant difference between Mandard groups.Conclusion Patients with a complete nodal response to chemotherapy have significantly improved outcomes despite a poor Mandard score. High Mandard score does not correspond with a non-response to chemotherapy in all cases and patients with nodal downstaging may still benefit from adjuvant chemotherapy.Subject terms: Oesophageal cancer, Surgical oncology 相似文献
8.
观察电针对缺血性脑卒中大鼠记忆功能及脑内突触囊泡蛋白(synaptic vesicular protein,SYN)的影响,探讨其可能的作用机制。方法 选取90 只SD大鼠随机分为模型组、电针组、假手术组,每组各30只。线拴法制作急性大脑中动脉缺血大鼠模型。电针组取“百会”“水沟”“内关”“三阴交”穴位,应用“醒脑开窍”法进行电针,每天电针30 min,连续电针6 d休1 d,7 d为一个疗程,首次电针干预在造模成功24 h后进行。模型组和假手术组不进行电针干预。大鼠分别按7、14、21 d 3个亚组进行运动及记忆功能评分,TTC染色测定脑梗死体积、Western blot检测脑内SYN的蛋白表达。结果 电针组运动功能评分较模型组显著降低(P<0.01),电针组进入隐藏区潜伏期时间较模型组显著缩短(P<0.01),电针组脑梗死率较模型组显著缩小(P<0.01),SYN的蛋白表达电针组较模型组明显增强(P<0.01)。假手术组无神经功能缺损及脑梗死灶,SYN表达最弱。结论 电针干预能减小脑梗死体积,上调脑内SYN的表达,进而促进缺血性脑卒中大鼠的记忆及运动等神经功能的恢复。 相似文献
9.
Michael E Egger Joanna M Ohlendorf Charles R Scoggins Kelly M McMasters Robert C G Martin II 《HPB : the official journal of the International Hepato Pancreato Biliary Association》2015,17(9):839-845
BackgroundThe aim of this paper is to assess the current state of quality and outcomes measures being reported for hepatic resections in the recent literature.MethodsMedline and PubMed databases were searched for English language articles published between 1 January 2002 and 30 April 2013. Two examiners reviewed each article and relevant citations for appropriateness of inclusion, which excluded papers of liver donor hepatic resections, repeat hepatectomies or meta-analyses. Data were extracted and summarized by two examiners for analysis.ResultsFifty-five studies were identified with suitable reporting to assess peri-operative mortality in hepatic resections. In only 35% (19/55) of the studies was the follow-up time explicitly stated, and in 47% (26/55) of studies peri-operative mortality was limited to in-hospital or 30 days. The time period in which complications were captured was not explicitly stated in 19 out of 28 studies. The remaining studies only captured complications within 30 days of the index operation (8/28). There was a paucity of quality literature addressing truly patient-centred outcomes.ConclusionQuality outcomes after a hepatic resection are inconsistently reported in the literature. Quality outcome studies for a hepatectomy should report mortality and morbidity at a minimum of 90 days after surgery. 相似文献
10.
R. Foley P. Kelly S. Gatault F. Powell 《Journal of the European Academy of Dermatology and Venereology》2021,35(1):62-72
Demodex mites are microscopic arachnids found in the normal skin of many mammals. In humans, it is well established that Demodex mite density is higher in patients with the skin condition rosacea, and treatment with acaricidal agents is effective in resolving symptoms. However, pathophysiology of rosacea is complex and multifactorial. In dogs, demodicosis is a significant veterinary issue, particularly the generalized form of the disease which can be fatal if untreated. In each species, clinical and molecular studies have shown that the host’s immunological interactions with Demodex mites are an important, but not fully understood, aspect of how Demodex can live in the skin either as a harmless commensal organism or as a pathogenic agent. This review outlines the role of Demodex mites in humans and dogs, considering morphology, prevalence, symptoms, diagnosis, histology treatment and pathogenesis. 相似文献